Business Description
MegaPro Biomedical Co Ltd
ISIN : TW0006827009
Description
MegaPro Biomedical Co Ltd is a nanomedicine development company.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 25.75 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 19.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 10.6 | |||||
| 3-Year EPS without NRI Growth Rate | 7.5 | |||||
| 3-Year FCF Growth Rate | 16.2 | |||||
| 3-Year Book Growth Rate | -0.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.11 | |||||
| 9-Day RSI | 40.28 | |||||
| 14-Day RSI | 41.39 | |||||
| 6-1 Month Momentum % | -34.55 | |||||
| 12-1 Month Momentum % | -40.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.02 | |||||
| Quick Ratio | 14.02 | |||||
| Cash Ratio | 10.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | -8.71 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -512375 | |||||
| Net Margin % | -444706.25 | |||||
| FCF Margin % | -392006.25 | |||||
| ROE % | -52.34 | |||||
| ROA % | -48.06 | |||||
| ROIC % | -99.27 | |||||
| ROC (Joel Greenblatt) % | -119.21 | |||||
| ROCE % | -51.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.29 | |||||
| Price-to-Tangible-Book | 3.33 | |||||
| EV-to-EBIT | -5.15 | |||||
| EV-to-EBITDA | -5.85 | |||||
| EV-to-Revenue | 22831.28 | |||||
| EV-to-FCF | -6.11 | |||||
| Price-to-Net-Current-Asset-Value | 4.01 | |||||
| Price-to-Net-Cash | 5.65 | |||||
| Earnings Yield (Greenblatt) % | -19.43 | |||||
| FCF Yield % | -13.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MegaPro Biomedical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 0.032 | ||
| EPS (TTM) (NT$) | -2.46 | ||
| Beta | 0.81 | ||
| Volatility % | 25.95 | ||
| 14-Day RSI | 41.39 | ||
| 14-Day ATR (NT$) | 0.414125 | ||
| 20-Day SMA (NT$) | 14.21 | ||
| 12-1 Month Momentum % | -40.54 | ||
| 52-Week Range (NT$) | 13 - 29.6 | ||
| Shares Outstanding (Mil) | 64.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MegaPro Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MegaPro Biomedical Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
MegaPro Biomedical Co Ltd Frequently Asked Questions
What is MegaPro Biomedical Co Ltd(ROCO:6827)'s stock price today?
The current price of ROCO:6827 is NT$14.00. The 52 week high of ROCO:6827 is NT$29.60 and 52 week low is NT$13.00.
When is next earnings date of MegaPro Biomedical Co Ltd(ROCO:6827)?
The next earnings date of MegaPro Biomedical Co Ltd(ROCO:6827) is .
Does MegaPro Biomedical Co Ltd(ROCO:6827) pay dividends? If so, how much?
MegaPro Biomedical Co Ltd(ROCO:6827) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers